Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.verified

KPRX

Price:

$3.4301

Market Cap:

$10.29M

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patient...[Read more]

Industry

Biotechnology

IPO Date

2015-02-13

Stock Exchange

NASDAQ

Ticker

KPRX

The Current Ratio as of December 2024 (TTM) for Kiora Pharmaceuticals, Inc. (KPRX) is 8.97

According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.97. This represents a change of -31.13% compared to the average of 13.03 of the last 4 quarters.

Kiora Pharmaceuticals, Inc. (KPRX) Historical Current Ratio (quarterly & annually)

How has KPRX Current Ratio performed in the past?

The mean historical Current Ratio of Kiora Pharmaceuticals, Inc. over the last ten years is 2.10. The current 8.97 Current Ratio has changed 42.53% with respect to the historical average. Over the past ten years (40 quarters), KPRX's Current Ratio was at its highest in in the March 2024 quarter at 21.02. The Current Ratio was at its lowest in in the December 2014 quarter at 0.04.

Quarterly (TTM)
Annual

Average

2.10

Median

2.27

Minimum

0.04

Maximum

5.59

Kiora Pharmaceuticals, Inc. (KPRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.24%

Maximum Annual Current Ratio = 5.59

Minimum Annual Increase = -79.96%

Minimum Annual Current Ratio = 0.04

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.9023.54%
20222.35-57.98%
20215.59446.90%
20201.02-66.59%
20193.0639.32%
20182.19284.72%
20170.570.33%
20160.57-79.42%
20152.766.24%
20140.04-79.96%

Kiora Pharmaceuticals, Inc. (KPRX) Average Current Ratio

How has KPRX Current Ratio performed in the past?

The current Current Ratio of Kiora Pharmaceuticals, Inc. (KPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.61

5-year avg

2.98

10-year avg

2.10

Kiora Pharmaceuticals, Inc. (KPRX) Current Ratio vs. Peers

How is KPRX’s Current Ratio compared to its peers?

Kiora Pharmaceuticals, Inc.’s Current Ratio is less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.64), greater than Hillstream BioPharma, Inc. (2.25), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), greater than Biodexa Pharmaceuticals Plc (2.16), greater than Unicycive Therapeutics, Inc. (3.61), greater than Cardio Diagnostics Holdings, Inc. (8.51), greater than PaxMedica, Inc. Common Stock (0.38), greater than Panbela Therapeutics, Inc. (0.26), greater than Palisade Bio, Inc. (3.31),

Build a custom stock screener for Kiora Pharmaceuticals, Inc. (KPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiora Pharmaceuticals, Inc. (KPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Kiora Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the highest Current Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 3-year average Current Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 5-year average Current Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

How does the current Current Ratio for Kiora Pharmaceuticals, Inc. (KPRX) compare to its historical average?